CB
THC Farmaceuticals, Inc.
CBDG · OTC
$0.02 +0.00% (+$0.00)
1M +200.00%
Market Cap $130.5K
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/FCF 0.21x
P/B 0.04x
EV/FFO N/A
Growth
84 /100
Growing Book val. growth 10.89%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
1 /100
Poor Asset turnover 0.00x
ROIC 1.09%
ROA 0.55%
Debt
81 /100
Low Net debt/EBITDA -5.59x
Debt/Equity 0.04x
Current ratio 0.12x
Stability
13 /100
Unstable EPS volatility 2,777.89%
Beta -8.64x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CBDG
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mark D. Grossman
Employees
2
Headquarters
Scottsdale